Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView™ System
Key Highlights
- ➤Spectral AI submits DeepView NTAP application to CMS through the alternative pathway
- ➤CMS determination expected August 2027
- ➤NTAP approval would generally begin October 2027 and last approximately three years
- ➤Qualifying cases may receive additional Medicare payment, generally limited to approximately 65% of estimated technology cost
- ➤FDA granted DeepView De Novo Classification in May 2026
Expert Statements
Vincent Capone, Chief Executive Officer of Spectral AI
“We are investing significant capital in pursuing additional reimbursement pathways as we recognize the importance of supporting hospitals as they incorporate the DeepView System into their clinical workflows and facilitate patient access to care for this innovative technology.”
Vincent Capone, Chief Executive Officer of Spectral AI
“An NTAP payment, if approved, would represent a meaningful component of the economic value proposition for hospital systems that adopt the DeepView System.”
Vincent Capone, Chief Executive Officer of Spectral AI
“It could help offset a meaningful portion of the incremental cost of incorporating this innovative technology into the patient workflow, while enabling clinicians to access rapid, objective information to support burn-wound assessment and treatment decisions.”
Vincent Capone, Chief Executive Officer of Spectral AI
“Additional reimbursement support could improve patient access to care and help reduce adoption barriers for eligible health systems, making it easier to integrate and utilize the DeepView System in appropriate inpatient settings.”
Vincent Capone, Chief Executive Officer of Spectral AI
“We will continue to evaluate other payment and reimbursement pathways that support our commercialization objectives.”
DALLAS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the submission of a New Technology Add-On Payment (NTAP) application to the Centers for Medicare & Medicaid Services (CMS) for its DeepView™ System utilizing the alternative pathway.
The NTAP program is designed to provide an additional hospital inpatient payment for eligible procedures involving new technologies or medical services that meet CMS requirements, helping to address the additional costs associated with incorporating innovative technologies into patient care while providing timely access to these advancements.
Get started
Create a free account to read the full story.